[Assessment of the studies. Important recombinant agents in treatment of rheumatoid arthritis]

Pharm Unserer Zeit. 2003;32(5):396-403. doi: 10.1002/pauz.200300039.

[Article in German]

Author

Joachim Peter Kaltwasser¹

Affiliation

¹ Bereich Rheumatologie Medizinische Klinik III Zentrum der Inneren Medizin J.W. Goethe-Universität Theodor Stern Kai 7 D-60590 Frankfurt am Main. kaltwasser@em.uni-frankfurt.de

PMID: 14526460
DOI: 10.1002/pauz.200300039

No abstract available

Publication types

Review

MeSH terms

Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / pathology
Clinical Trials as Topic
Humans
Recombinant Proteins / therapeutic use*

Substances

Antirheumatic Agents
Recombinant Proteins